Darren W. Grabe

Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

Gary R. Matzke, George R. Aronoff, Arthur J. Atkinson et al. · Kidney International · 2011 · 442 citations · Full text

Drug Interactions, Hemodialysis, Renal Function +12

Chromium Picolinate Toxicity

Jennifer Cerulli, Darren W. Grabe, Isabelle Gauthier et al. · Annals of Pharmacotherapy · 1998 · 209 citations

Use of Pharmacokinetic and Pharmacodynamic Principles To Determine Optimal Administration of Daptomycin in Patients Receiving Standardized Thrice-Weekly Hemodialysis

Nimish Patel, Katie E. Cardone, Darren W. Grabe et al. · Antimicrobial Agents and Chemotherapy · 2011 · 40 citations · Full text

Quantifying home medication regimen changes and quality of life in patients receiving nocturnal home hemodialysis

Katie E. Cardone, Harold J. Manley, Darren W. Grabe et al. · Hemodialysis International · 2011 · 40 citations

Family Medicine, Quality Of Life, Anemia Medications +19

Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers

Kevin M. Sowinski, Bruce A. Mueller, Darren W. Grabe et al. · American Journal of Kidney Diseases · 2001 · 36 citations

Bioengineering Model, Bioanalysis, Cefazolin Dialytic Clearance +3